Evolus (EOLS) Enterprise Value (2018 - 2026)
Evolus' (EOLS) quarterly Enterprise Value came in at -$49.8 million in Q1 2026, up 26.66% YoY from -$39.3 million in Q1 2025, and up 7.49% on a QoQ basis from -$53.8 million in Q4 2025.
Evolus (EOLS) Enterprise Value (2018 - 2026) Analysis & Trends
Evolus (EOLS) has 9 years of Enterprise Value data on file, last reported at -$49.8 million in Q1 2026.
- Quarterly Enterprise Value rose 26.66% year-over-year to -$49.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$49.8 million (up 26.66% YoY) and the FY2025 annual result came in at -$53.8 million, up 38.1% from the prior year.
- Enterprise Value grew to -$49.8 million in Q1 2026, from -$53.8 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$31.5 million in Q1 2023 to a low of -$106.7 million in Q1 2022.
- A 5-year average of -$66.2 million and a median of -$62.8 million in 2023 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value plunged 381.13% — and 2023, when it surged 70.5%.
- Tracing EOLS's Enterprise Value over 5 years: stood at -$53.9 million in 2022, then declined by 16.53% to -$62.8 million in 2023, then sank by 38.37% to -$87.0 million in 2024, then jumped by 38.1% to -$53.8 million in 2025, then climbed by 7.49% to -$49.8 million in 2026.
- The last three Enterprise Value figures came in at -$49.8 million (Q1 2026), -$53.8 million (Q4 2025), and -$43.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | Evolus | 552.49 Mn | 507.32 Mn | 57.18 Mn | -45.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -45.17 Mn |
| Mar 31, 2026 | -49.79 Mn |
| Dec 31, 2025 | -53.83 Mn |
| Sep 30, 2025 | -43.52 Mn |
| Jun 30, 2025 | -61.74 Mn |
| Mar 31, 2025 | -67.89 Mn |
| Dec 31, 2024 | -86.95 Mn |
| Sep 30, 2024 | -85.04 Mn |
| Jun 30, 2024 | -93.67 Mn |
| Mar 31, 2024 | -96.96 Mn |
| Dec 31, 2023 | -62.84 Mn |
| Sep 30, 2023 | -38.69 Mn |
| Jun 30, 2023 | -41.71 Mn |
| Mar 31, 2023 | -31.46 Mn |
| Dec 31, 2022 | -53.92 Mn |
| Sep 30, 2022 | -65.57 Mn |
| Jun 30, 2022 | -84.48 Mn |
| Mar 31, 2022 | -106.67 Mn |
| Dec 31, 2021 | -146.26 Mn |
| Sep 30, 2021 | -107.80 Mn |